Vycor Medical (VYCO) Change in Accured Expenses (2010 - 2026)

Vycor Medical (VYCO) has reported Change in Accured Expenses for 17 consecutive years, with $11967.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 131.84% year-over-year to $11967.0 in Q2 2026; TTM through Jun 2026 was $25183.0, a 156.55% increase from a year earlier, with the FY2025 full-year figure at -$67346.0, down 239.92% from the prior year.
• Change in Accured Expenses was $11967.0 for Q2 2026 at Vycor Medical, up from $11836.0 in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $104627.0 in Q3 2025 and troughed at -$103247.0 in Q4 2025.
• A 5-year average of $6539.9 and a median of $11835.5 in 2023 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses jumped 12266.67% in 2024 and sank 963.7% in 2025, its largest moves.
• Over 5 years, Change in Accured Expenses stood at $22983.0 in 2022, then advanced by 6.87% to $24563.0 in 2023, then plunged by 51.33% to $11954.0 in 2024, then slumped by 963.7% to -$103247.0 in 2025, then surged by 111.59% to $11967.0 in 2026.
• The last three Change in Accured Expenses figures came in at $11967.0 (Q2 2026), $11836.0 (Q1 2026), and -$103247.0 (Q4 2025), per Business Quant data.